医院手术量与大复杂性主动脉瘤腔内修复术围术期死亡率的关联:全国队列研究
该全国性强制质量登记研究纳入2016年1月至2020年1月荷兰外科动脉瘤审计中所有接受复杂EVAR(FEVAR或BEVAR)的患者,评估医院年手术量与围术期死亡率的关系。共纳入694例患者(FEVAR 539例,BEVAR 155例),FEVAR围术期死亡率为4.5%,BEVAR为5.2%。年手术量≥13例的医院与<9例的医院相比,校正混杂因素后围术期死亡率更低(9.1% vs 2.5%,P=0.008)。
要点
- 复杂EVAR围术期死亡率FEVAR为4.5%,BEVAR为5.2%。
- 年手术量<9例医院围术期死亡率为9.1%,≥13例医院为2.5%(P=0.008)。
- 校正混杂因素后,年手术量≥13例与围术期死亡率降低相关。
核心结论
- 全国性强制质量登记数据显示,医院手术量对复杂EVAR围术期死亡率有显著影响,高手术量复杂EVAR中心死亡率更低。
研究设计与样本
- 全国性队列研究,纳入荷兰外科动脉瘤审计中2016年1月至2020年1月所有接受复杂EVAR(FEVAR或BEVAR)的患者,共694例(FEVAR 539例,BEVAR 155例)。
- 采用多因素logistic回归分析医院年手术量对围术期死亡率的影响,并按年手术量四分位数分层。
主要发现
- FEVAR围术期死亡率为4.5%,BEVAR为5.2%;术后并发症率分别为30.1%和48.7%。
- 年手术量第一四分位医院<9例/年,第二、三、四分位分别为9-12、13-22、≥23例/年。
- 最高手术量医院治疗的患者显著更复杂。
- 复杂EVAR围术期死亡率在年手术量<9例的医院为9.1%,在年手术量≥13例的医院为2.5%(P=0.008)。
- 校正混杂因素后,年手术量≥13例与围术期死亡率降低相关(相较于年手术量<9例的医院)。
关键数值与推荐
- 年手术量分层:第一四分位<9例/年,第二四分位9-12例/年,第三四分位13-22例/年,第四四分位≥23例/年。
- 围术期死亡率:年手术量<9例医院9.1% vs 年手术量≥13例医院2.5%(P=0.008)。
- FEVAR围术期死亡率4.5%,BEVAR围术期死亡率5.2%。
- 术后并发症率:FEVAR 30.1%,BEVAR 48.7%。
临床怎么用
- 复杂EVAR(FEVAR或BEVAR)的围术期死亡率与医院年手术量相关,高手术量中心死亡率更低。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluate nationwide perioperative outcomes of complex EVAR and assess the volume-outcome association of complex EVAR. SUMMARY OF BACKGROUND DATA: Endovascular treatment with fenestrated (FEVAR) or branched (BEVAR) endografts is progressively used for excluding complex aortic aneurysms (complex AAs). It is unclear if a volume-outcome association exists in endovascular treatment of complex AAs (complex EVAR). METHODS: All patients prospectively registered in the Dutch Surgical Aneurysm Audit who underwent complex EVAR (FEVAR or BEVAR) between January 2016 and January 2020 were included. The effect of annual hospital volume on perioperative mortality was examined using multivariable logistic regression analyses. Patients were stratified into quartiles based on annual hospital volume to determine hospital volume categories. RESULTS: We included 694 patients (539 FEVAR patients, 155 BEVAR patients). Perioperative mortality following FEVAR was 4.5% and 5.2% following BEVAR. Postoperative complication rates were 30.1% and 48.7%, respectively. The first quartile hospitals performed <9 procedures/yr; second, third, and fourth quartile hospitals performed 9-12, 13-22, and ≥23 procedures/yr. The highest volume hospitals treated the significantly more complex patients. Perioperative mortality of complex EVAR was 9.1% in hospitals with a volume of < 9, and 2.5% in hospitals with a volume of ≥13 (P = 0.008). After adjustment for confounders, an annual volume of ≥13 was associated with less perioperative mortality compared to hospitals with a volume of < 9. CONCLUSIONS: Data from this nationwide mandatory quality registry shows a significant effect of hospital volume on perioperative mortality following complex EVAR, with high volume complex EVAR centers demonstrating lower mortality rates.
引用
- Alberga AJ, von Meijenfeldt GCI, Rastogi V, et al. Association of Hospital Volume with Perioperative Mortality of Endovascular Repair of Complex Aortic Aneurysms: A Nationwide Cohort Study. Ann Surg. 2021. PMID: 34913891. doi:10.1097/SLA.0000000000005337
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。